Skip to content
value.today

PolyPid Ltd. vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $103 M for PolyPid Ltd., 5.0 times as much (market caps of Aug 1, 2026 for PolyPid Ltd. and Oct 6, 2026 for Regenxbio Inc.). PolyPid Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $34 M for PolyPid Ltd. and $194 M for Regenxbio Inc.
  • Regenxbio Inc. employs more people: 372 against 59 at PolyPid Ltd.

Market value, the same start = 100

From Jan 2021: how each one's value moved, whatever its size.

0255075100202120222023202420252026PolyPid Ltd. 56Regenxbio Inc. 30

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Regenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasurePolyPid Ltd.
PYPD · #18,597 in the world
Regenxbio Inc.
RGNX · #12,428 in the world
Profile
Country🇮🇱 Israel🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$103 M$513 M
Revenue—$170 M
Net income$-34 M▲ best$-194 M
Employees59372
Valuation
Price to sales—3.3×
Price to book9.4×5.0×
Free cash flow yield-27.2%-24.6%▲ best
Profitability
Operating margin—-94.6%
Net margin—-113.8%
Return on equity-366.4%-107.0%▲ best
Growth
Revenue growth—104.5%
Revenue growth, 3 years a year—14.8%
Earnings per share growth-57.4%—
Cash
Free cash flow margin—-74.1%
Altman Z-score zone—distress
Data as ofMarket cap Aug 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, PolyPid Ltd. or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $103 M for PolyPid Ltd., 5.0 times as much (market caps of Aug 1, 2026 for PolyPid Ltd. and Oct 6, 2026 for Regenxbio Inc.). PolyPid Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, PolyPid Ltd. or Regenxbio Inc.?

Both made a net loss: $34 M for PolyPid Ltd. and $194 M for Regenxbio Inc.

Which has more employees, PolyPid Ltd. or Regenxbio Inc.?

Regenxbio Inc. employs more people: 372 against 59 at PolyPid Ltd.

Sources#

Every figure on this page comes from these, with the date shown next to it.